EEF1A2 and neoplasm: In particular, STn and ST antigens seem to be potent agonists of inhibitory siglecs, as macrophage Siglec-15 [48] and -9 [126], respectively, inducing tumour-associated macrophage (TAM)-like phenotypes and permitting immune scape (Fig. 2).